APA (7th ed.) Citation

MM, M., W, S., F, I., RV, L., JD, P., JH, S., & M, G. (2024). Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022. Journal of neuro-oncology, 169(1), 25. https://doi.org/10.1007/s11060-024-04682-7

Chicago Style (17th ed.) Citation

MM, Mrugala, Shi W, Iwomoto F, Lukas RV, Palmer JD, Suh JH, and Glas M. "Global Post‑marketing Safety Surveillance of Tumor Treating Fields (TTFields) Therapy in over 25,000 Patients with CNS Malignancies Treated Between 2011-2022." Journal of Neuro-oncology 169, no. 1 (2024): 25. https://doi.org/10.1007/s11060-024-04682-7.

MLA (9th ed.) Citation

MM, Mrugala, et al. "Global Post‑marketing Safety Surveillance of Tumor Treating Fields (TTFields) Therapy in over 25,000 Patients with CNS Malignancies Treated Between 2011-2022." Journal of Neuro-oncology, vol. 169, no. 1, 2024, p. 25, https://doi.org/10.1007/s11060-024-04682-7.